Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Flavia Fedeles, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Asdourian MS, Shah N, Jacoby TV, Tiao J, Fedeles F. Dercum's disease: a retrospective cohort study. J Am Acad Dermatol. 2022 Oct 10. PMID: 36228943.
    Citations:    Fields:    
  2. Raef HS, Williams M, Fedeles F. Topical treatments for erythromelalgia. Dermatol Ther. 2022 Nov; 35(11):e15860. PMID: 36164837.
    Citations:    Fields:    Translation:Humans
  3. Tiao J, Gaffney R, Fedeles F. A Retrospective Study of Calcinosis Cutis in Patients With Systemic Lupus Erythematosus. J Drugs Dermatol. 2022 Oct 01; 21(10):1137. PMID: 36219042.
    Citations:    Fields:    Translation:Humans
  4. Theisen E, Tiao J, Fedeles F. Periorbital discoid lupus erythematosus: A retrospective study. JAAD Case Rep. 2022 Jul; 25:78-82. PMID: 35783074; PMCID: PMC9243042.
  5. Otto T, Argobi Y, Smith G, Fedeles F. A Retrospective Study of Idiopathic Granulomatous Mastitis Treatment and Outcomes. J Drugs Dermatol. 2022 Apr 01; 21(4):438-440. PMID: 35389582.
    Citations:    Fields:    Translation:Humans
  6. Stephens MR, Moore DF, Dau J, Jobbagy S, Neel VA, Bolster MB, Fedeles F. A case of generalized morphea profunda following SARS-CoV-2 infection. JAAD Case Rep. 2022 May; 23:20-23. PMID: 35308063; PMCID: PMC8917007.
  7. Otto TS, Argobi Y, Lerwill MJ, Smith GP, Fedeles F. A retrospective study of idiopathic granulomatous mastitis diagnosis and clinical presentation. J Am Acad Dermatol. 2022 02; 86(2):467-469. PMID: 34610382.
    Citations:    Fields:    Translation:Humans
  8. Raef HS, Nassim JS, Fedeles F. Indurated plaques on the back: distinguishing stiff skin syndrome from scleredema and morphea. Int J Dermatol. 2022 10; 61(10):e393-e394. PMID: 34411278.
    Citations:    Fields:    
  9. D'Gama JD, Hashemi DA, Fedeles F. A case of paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma. JAAD Case Rep. 2021 Sep; 15:88-91. PMID: 34458535.
  10. Argobi Y, Fedeles F, Schoenfeld SR. A case of Wong-type dermatomyositis treated with rituximab and IVIG. Australas J Dermatol. 2021 Feb; 62(1):e86-e87. PMID: 32671816.
    Citations:    Fields:    Translation:Humans
  11. Lakdawala N, Fedeles F. Vasculitis: Kids are not just little people. Clin Dermatol. 2017 Nov - Dec; 35(6):530-540. PMID: 29191345.
    Citations: 4     Fields:    Translation:Humans
  12. Fedeles F, Cha J, Chaump M, Theroux B, Farrell D, Dufresne R, Robinson-Bostom L. Panfollicular carcinoma or trichoblastic carcinoma with panfollicular differentiation? J Cutan Pathol. 2013 Nov; 40(11):976-81. PMID: 24320809.
    Citations: 1     Fields:    Translation:Humans
  13. Lakdawala N, Babalola O, Fedeles F, McCusker M, Ricketts J, Whitaker-Worth D, Grant-Kels JM. The role of nutrition in dermatologic diseases: facts and controversies. Clin Dermatol. 2013 Nov-Dec; 31(6):677-700. PMID: 24160272.
    Citations: 6     Fields:    Translation:Humans
  14. Fedeles F, Murphy M, Rothe MJ, Grant-Kels JM. Nutrition and bullous skin diseases. Clin Dermatol. 2010 Nov-Dec; 28(6):627-43. PMID: 21034987.
    Citations: 9     Fields:    Translation:Humans
  15. Brown MF, Bahnck KB, Blumberg LC, Brissette WH, Burrell SA, Driscoll JP, Fedeles F, Fisher MB, Foti RS, Gladue RP, Guzman-Martinez A, Hayward MM, Lira PD, Lillie BM, Lu Y, Lundquist GD, McElroy EB, McGlynn MA, Paradis TJ, Poss CS, Roache JH, Shavnya A, Shepard RM, Trevena KA, Tylaska LA. Piperazinyl CCR1 antagonists--optimization of human liver microsome stability. Bioorg Med Chem Lett. 2007 Jun 01; 17(11):3109-12. PMID: 17383873.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  16. Donnelly M, Fedeles F, Wirstam M, Siegbahn PE, Zimmer M. Computational analysis of the autocatalytic posttranslational cyclization observed in histidine ammonia-lyase. A comparison with green fluorescent protein. J Am Chem Soc. 2001 May 23; 123(20):4679-86. PMID: 11457276.
    Citations: 4     Fields:    Translation:Cells
  17. Fedeles F, Zimmer M. Conformational/configurational analysis of all the binding geometries of cobalt(III) bleomycin. Inorg Chem. 2001 Mar 26; 40(7):1557-61. PMID: 11261964.
    Citations: 1     Fields:    Translation:Cells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Fedeles's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (86)
Co-Authors (14)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.